| 000 | 01912 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517181430.0 | ||
| 264 | 0 | _c20190805 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1931-3543 | ||
| 024 | 7 |
_a10.1016/j.chest.2017.10.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRonan, Nicola J | |
| 245 | 0 | 0 |
_aCORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor. _h[electronic resource] |
| 260 |
_bChest _c02 2018 |
||
| 300 |
_a395-403 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAminophenols _xtherapeutic use |
| 650 | 0 | 4 |
_aChloride Channel Agonists _xtherapeutic use |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCystic Fibrosis Transmembrane Conductance Regulator _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aQuinolones _xtherapeutic use |
| 650 | 0 | 4 |
_aRadiography, Thoracic _xmethods |
| 650 | 0 | 4 |
_aSaliva _xmicrobiology |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aEinarsson, Gisli G | |
| 700 | 1 | _aTwomey, Maria | |
| 700 | 1 | _aMooney, Denver | |
| 700 | 1 | _aMullane, David | |
| 700 | 1 | _aNiChroinin, Muireann | |
| 700 | 1 | _aO'Callaghan, Grace | |
| 700 | 1 | _aShanahan, Fergus | |
| 700 | 1 | _aMurphy, Desmond M | |
| 700 | 1 | _aO'Connor, Owen J | |
| 700 | 1 | _aShortt, Cathy A | |
| 700 | 1 | _aTunney, Michael M | |
| 700 | 1 | _aEustace, Joseph A | |
| 700 | 1 | _aMaher, Michael M | |
| 700 | 1 | _aElborn, J Stuart | |
| 700 | 1 | _aPlant, Barry J | |
| 773 | 0 |
_tChest _gvol. 153 _gno. 2 _gp. 395-403 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.chest.2017.10.005 _zAvailable from publisher's website |
| 999 |
_c27690198 _d27690198 |
||